Canopy Growth Corporation has announced robust financial results for its second quarter of fiscal year 2026, ending September 30, 2025, revealing a significant 30% surge in its Canada adult-use cannabis revenue. This key metric reached $24 million, underscoring a focused commercial strategy and improved execution within its domestic market. The company also saw its Canada medical cannabis revenue grow by a substantial 17% to $22 million for the quarter.
Driving Growth in Canadian Cannabis Markets
The performance in Canada’s adult-use sector is a pivotal development for Canopy Growth, reflecting increased market penetration and successful product launches. The company attributed this growth in part to strong performance from infused pre-roll joints and new All-In-One vapes from its well-regarded Tweed and 7ACRES brands. Similarly, the 17% rise in medical cannabis revenue was bolstered by a greater number of insured patients, larger order sizes, and an expanded product assortment available to medical consumers.
Financial Turnaround and Operational Discipline
Beyond top-line growth in its core cannabis segments, Canopy Growth demonstrated significant progress in its financial health. Consolidated net revenue increased by 6% year-over-year to $67 million. More critically, the company reported a substantially reduced operating loss from continuing operations, which improved by 63% to $17 million compared to the same period last year. The Adjusted EBITDA loss also narrowed considerably, coming in at $3 million, a marked improvement from $6 million in the prior year’s quarter.
Canopy Growth concluded the quarter with a healthier balance sheet, holding $298 million in cash and cash equivalents, which exceeded its debt balances by $70 million. This strengthened financial position has resolved previous concerns regarding the company’s ability to continue as a going concern. Further demonstrating its commitment to financial discipline, Canopy Growth made prepayments totaling $50 million against its senior secured term loan during the quarter, fulfilling debt reduction obligations ahead of schedule.
Strategic Expansion and Leadership Appointments
In parallel with its operational improvements, Canopy Growth is actively pursuing strategic growth initiatives. Canopy USA, a subsidiary, has partnered with JP Brand Advisors to enhance the distribution of Wana Wellness hemp-based beverages and gummies across the United States. This collaboration aims to leverage JP Brand Advisors’ expertise in beverage alcohol and functional beverage distribution to scale Wana’s presence in a growing market segment driven by evolving consumer preferences for non-alcoholic and hemp-infused products.
Adding to its strategic leadership, Tom Stewart has been appointed as the permanent Chief Financial Officer. Stewart, who served as Interim CFO since July 2025, brings extensive experience from his tenure on the company’s senior finance leadership team since 2019 and his prior roles at Constellation Brands. His permanent appointment reinforces Canopy Growth’s focus on financial stability, operational discipline, and long-term value creation as outlined in its fiscal year 2026 strategy.
Navigating Industry Trends and Future Outlook
Canopy Growth’s recent performance aligns with broader trending developments in the Canadian cannabis sector, where consumer spending on legal products continues to dominate, with a noticeable shift towards categories like edibles and beverages. While international markets cannabis revenue saw a decrease of 39% due to supply chain issues in Europe, and Storz & Bickel vaporizer revenue declined 10%, the company’s core Canadian operations are showing considerable strength.
CEO Luc Mongeau expressed confidence in the company’s trajectory, stating, “We’re building a stronger, more competitive company defined by continued momentum in Canada adult-use cannabis, consistent growth in Canada medical cannabis, and a disciplined approach to strengthening our balance sheet”. The company anticipates sustained progress and expects to deliver results in the quarters ahead, supported by its revitalized financial footing and strategic market positioning. This positive news adds to the ongoing discourse surrounding the cannabis industry’s evolution and potential for future growth.
